These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 7591967)
1. Hyperfractionated and hypofractionated radiation therapy for human malignant glioma xenograft in nude mice. Hasegawa M; Niibe H; Mitsuhashi N; Yamakawa M; Kato S; Furuta M; Kazumoto T; Hayakawa K; Nakazato Y Jpn J Cancer Res; 1995 Sep; 86(9):879-84. PubMed ID: 7591967 [TBL] [Abstract][Full Text] [Related]
2. The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine. Halperin EC; Brizel DM; Honore G; Sontag MR; Griffith OW; Bigner DD; Friedman HS Int J Radiat Oncol Biol Phys; 1992; 24(1):103-9. PubMed ID: 1512145 [TBL] [Abstract][Full Text] [Related]
3. Protracted exposure radiosensitization of experimental human malignant glioma. Williams JA; Williams JR; Yuan X; Dillehay LE Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941 [TBL] [Abstract][Full Text] [Related]
4. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma. Yuan X; Tabassi K; Williams JA Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162 [TBL] [Abstract][Full Text] [Related]
5. Response of xenografts of human malignant gliomas and squamous cell carcinomas to fractionated irradiation. Baumann M; DuBois W; Pu A; Freeman J; Suit HD Int J Radiat Oncol Biol Phys; 1992; 23(4):803-9. PubMed ID: 1319979 [TBL] [Abstract][Full Text] [Related]
6. Ultrafractionation in A7 human malignant glioma in nude mice. Krause M; Hessel F; Wohlfarth J; Zips D; Hoinkis C; Foest H; Petersen C; Short SC; Joiner MC; Baumann M Int J Radiat Biol; 2003 Jun; 79(6):377-83. PubMed ID: 12963539 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the response of human FaDu squamous cell carcinoma in nude mice after hypofractionated-accelerated regimens and "curative" fractionation schedules. Appold S; Baumann M; Petersen C; Horn K; Eichhorn F Strahlenther Onkol; 1998 Jun; 174(6):315-9. PubMed ID: 9645213 [TBL] [Abstract][Full Text] [Related]
8. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02). Corn BW; Yousem DM; Scott CB; Rotman M; Asbell SO; Nelson DF; Martin L; Curran WJ Cancer; 1994 Nov; 74(10):2828-35. PubMed ID: 7954244 [TBL] [Abstract][Full Text] [Related]
9. Topotecan can compensate for protracted radiation treatment time effects in high grade glioma xenografts. Pinel S; Chastagner P; Merlin JL; Marchal C; Taghian A; Barberi-Heyob M J Neurooncol; 2006 Jan; 76(1):31-8. PubMed ID: 16311843 [TBL] [Abstract][Full Text] [Related]
10. Human malignant glioma cell lines are sensitive to low radiation doses. Beauchesne PD; Bertrand S; Branche R; Linke SP; Revel R; Dore JF; Pedeux RM Int J Cancer; 2003 May; 105(1):33-40. PubMed ID: 12672027 [TBL] [Abstract][Full Text] [Related]
11. Fractionated Radiotherapy of Intracranial Gliomas. Ghia AJ Prog Neurol Surg; 2018; 31():38-47. PubMed ID: 29393175 [TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527 [TBL] [Abstract][Full Text] [Related]
13. Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo. Krause M; Wohlfarth J; Georgi B; Pimentel N; Dorner D; Zips D; Eicheler W; Hessel F; Short SC; Joiner MC; Baumann M Int J Radiat Biol; 2005 Oct; 81(10):751-8. PubMed ID: 16449082 [TBL] [Abstract][Full Text] [Related]
14. [The role of age and tumor grade in the choice of fractionation regimen in patients with high-grade gliomas]. Izmaĭlov TR; Pan'shin GA; Datsenko PV Vopr Onkol; 2012; 58(3):374-9. PubMed ID: 22888654 [TBL] [Abstract][Full Text] [Related]
15. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma. Williams JA; Dillehay LE; Tabassi K; Sipos E; Fahlman C; Brem H J Neurooncol; 1997 May; 32(3):181-92. PubMed ID: 9049879 [TBL] [Abstract][Full Text] [Related]
16. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma. Yuan X; Dillehay LE; Williams JR; Williams JA Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303 [TBL] [Abstract][Full Text] [Related]
17. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548 [TBL] [Abstract][Full Text] [Related]
18. Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma. Shibamoto Y; Nishimura Y; Tsutsui K; Sasai K; Takahashi M; Abe M Jpn J Clin Oncol; 1997 Feb; 27(1):31-6. PubMed ID: 9070338 [TBL] [Abstract][Full Text] [Related]
19. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas. Yuan X; Dillehay LE; Williams JR; Shastri VR; Williams JA Int J Cancer; 2001 Apr; 96(2):118-25. PubMed ID: 11291095 [TBL] [Abstract][Full Text] [Related]
20. Impact of increased cell loss on the repopulation rate during fractionated irradiation in human FaDu squamous cell carcinoma growing in nude mice. Hessel F; Petersen C; Zips D; Krause M; Pfitzmann D; Thames HD; Baumann M Int J Radiat Biol; 2003 Jul; 79(7):479-86. PubMed ID: 14530155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]